Protective role of human intravenous immunoglobulin from influenza A virus infection in mice

Open Hematology Journal

Volumn 6, Issue 1, 2012, Pages 8-11

  Hagiwara, Katsuro ^a   Kawami, Sachiyo ^a   Kato Mori, Yuuko ^a   Kubota Koketsu, Ritsuko ^b,e   Tsujikawa, Muneo ^c   Urayama, Takeru ^b,c   Yunoki, Mikihiro ^a,b,c   Takahashi, Kazuo ^d   Ikuta, Kazuyoshi ^b  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Benesis Corporation   (Japan)

^d OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^e The Research Foundation for Microbial Diseases of Osaka University   (Japan)

Author keywords

2009 Pandemic Influenza; Animal model; Influenza; IVIG

Indexed keywords

HUMAN IMMUNOGLOBULIN; OSELTAMIVIR; UNCLASSIFIED DRUG; VENOGLOBULIN IH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HISTOPATHOLOGY; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VIRUS A; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCID MOUSE; SURVIVAL RATE; VIRUS INFECTIVITY;

EID: 84863933372     PISSN: None     EISSN: 18742769     Source Type: Journal    
DOI: 10.2174/1874276901206010008     Document Type: Article

References (12)

1. Study group appointed for influenza encephalopathy, Ministry of Health, Labour and Welfare of Japan. Guideline for influenza encephalopathy. 2009. [In Japanese]. Available at: http://www. mhlw.go.jp/kinkyu/kenkou/influenza/hourei/2009/09/dl/info0925-01.pdf
2. The Japanese Respiratory Society. The JRS Guidelines for the Management of Community-Acquired Pneumonia in Adults. Nihon Rinsho 2003; 61(Suppl 2): 677-81. [In Japanese].
3. Yunoki M, Kubota-Koketsu R, Urayama T, et al. Significant neutralizing activity of human immunoglobulin preparations against pandemic 2009 H1N1. Br J Haematol 2010; 148: 953-5.
4. Hong DK, Tremoulet AH, Burns JC, Lewis DB. Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations. Pediatr Infect Dis J 2011; 30: 67-9.
5. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmne and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747-55.
6. Ogino Y, Takizawa D, Hayashi Y, et al. A case of influenza virusassociated encephalopathy successfully treated with a combination of mild hypothermia, anticytokine and anti virus. J Jpn Soc Intensive Care Med 2004; 11: 443-8. [In Japanese]
7. Nakao T, Hamanishi T, Goto S, et al. Three case of influenza viral pneumonia. J Wakayama Med Soc 2001; 52: 405-10. [In Japanese]
8. Casper C, Englund J, Boeckh M. How I treat influenza in patients with hematologic malignancies. Blood 2010; 115: 1331-42.
9. Gordon CL, Johnson PDR, Permezel M, et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G2 subclass deficiency. Clin Infect Dis 2010; 50: 672-8.
10. Palacios G, Hornig M, Cisterna D, et al. Streptococcus Pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. Plos One 2010; 4: e8450.
11. Murray RJ, Robinson JO, White JN, et al. Community-acquired Pneumonia due to pandemic A (H1N1) 2009 influenza virus and Methicillin resistant Staphylococcus aureus co-infection. Plos One 2010; 5: e8705.
12. Katz J, Hancock K, Veguilla V, et al. Serum cross-reactive antibody response to a Novel Influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009; 58: 521-4.